Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

Author： Vereide A.B.   Arnes M.   Straume B.   Maltau J.M.   Orbo A.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.91, Iss.3, 2003-12, pp. : 526-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Effect of Medroxyprogesterone Acetate on Angiogenesis in Complex Endometrial Hyperplasia

By Abulafia O.   Triest W.E.   Adcock J.T.   Sherer D.M.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 193-198

Elsevier

Access to resources Recommend Favorite

Concomitant Endometrial Hyperplasia in Patients with Endometrial Carcinoma

By Gucer F.   Reich O.   Tamussino K.   Bader A.A.   Pieber D.   Scholl W.   Haas J.   Petru E.  

Gynecologic Oncology, Vol. 69, Iss. 1, 1998-04 ,pp. : 64-68

Elsevier

Access to resources Recommend Favorite

Apoptosis May Be an Early Event of Progestin Therapy for Endometrial Hyperplasia

By Amezcua C.A.   Lu J.J.   Felix J.C.   Stanczyk F.Z.   Zheng W.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 169-176

Elsevier

Access to resources Recommend Favorite

Endometrial Carcinoma Associated with Hyperplasia- Immunohistochemical Study of Angiogenesis and p53 Expression

By Kaku T.   Kamura T.   Hirakawa T.   Sakai K.   Amada S.   Kobayashi H.   Nakano H.  

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 51-55

Elsevier

Access to resources Recommend Favorite

Biomarkers of Intrinsic Angiogenic and Anti-angiogenic Activity in Patients with Endometrial Hyperplasia and Endometrial Cancer

By Shaarawy Mohamed   El-Sharkawy Sherif A.  

Acta Oncologica, Vol. 40, Iss. 4, 2001-06 ,pp. : 513-518

Informa Healthcare

Access to resources Recommend Favorite